• Top Rural and Community Hospitals by Chartis
  • 2023 Bill Aston Award for Quality
  • 2024 Outstanding Rural Health Program Award

    Hospital Quality Improvement Initiative

    Welcome

    TMF Health Quality Institute helps hospitals participating in the Hospital Quality Improvement Initiative (HQIC) reduce all-cause patient harm and readmissions in rural, medically underserved and vulnerable populations. The Centers for Medicare & Medicaid Services has contracted with TMF to work with qualifying hospitals. Together, we will identify solutions to improve health care outcomes and improve patient care in your facility.

    As a member of the HQIC network, you have access to the latest news, resources, learning opportunities and forum discussions. Your hospital and health care providers work hard every day to provide safe reliable quality care. TMF looks forward to partnering with you to improve the effectiveness, efficiency, economy and quality of services delivered to your patients. Download our fact sheet (PDF) to learn more.

    These items also available in the Resource Library 
    The Public Health Data Strategy
    The updated data modernization strategy for 2024-2025 lays out priority work for the next two years to continue to improve our capabilities for early threat detection and real-time monitoring across all levels of public health.
    SNAP and WIC recipients in Texas can apply for replacement benefits
    The Texas Health and Human Services Commission received federal approval allowing recipients of the Supplemental Nutrition Assistance Program (SNAP) to apply for replacement benefits for food lost or destroyed from Hurricane Beryl. The Special Supplemental Nutrition Program for Women, Infants and Children (WIC) is also replacing food and formula benefits lost during the hurricane.
    Medicare coverage is now available for Alzheimer’s drug Kisunla
    On July 2, 2024, the Centers for Medicare & Medicaid Services announced that Medicare coverage is now available for Kisunla (donanemab-azbt) following the Food and Drug Administration's (FDA) move to grant traditional approval to the drug that treats people with Alzheimer’s disease. Kisunla joins Leqembi (the brand name for lecanemab-irmb) as the second monoclonal amyloid beta antibody treatment granted traditional FDA approval for Alzheimer’s disease.
    Summer COVID Wave Emerges
    As "FLiRT" coronavirus variants account for about 77% of infections, COVID-19 cases are ticking upward this summer, according to the Centers for Disease Control and Prevention (CDC) data. This Becker’s Hospital Review article highlights five important notes about increasing COVID-19 cases.
    CDC Recommends Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season
    The Centers for Disease Control and Prevention (CDC) recommend the updated 2024-2025 COVID-19 vaccines and the updated 2024-2025 flu vaccines to protect against severe COVID-19 and flu this fall and winter. It is safe to receive COVID-19 and flu vaccines at the same visit.
    1 2 3 4 5Next